Kevin Muñoz Forti

Kevin Muñoz Forti

Auto-generated profile, based on publicly available information

Kevin Muñoz Forti


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2022 in Purinergic Signalling
Verified
Journal Article
Closed access
PDF file
KJKimberly Jasmer
Kimberly Jasmer
KFKevin Muñoz Forti
Kevin Muñoz Forti
LWLucas T. Woods
Lucas T. Woods
SCSeunghee Cha
Seunghee Cha
GWGary A. Weisman
Gary A. Weisman

1 February 2015 in Biophysical Chemistry
Verified
Journal Article
Closed access
GLGinny Lai
Ginny Lai
KFKevin Muñoz Forti
Kevin Muñoz Forti
RRRobert Renthal
Robert Renthal

23 December 2024 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
KJKimberly Jasmer
Kimberly Jasmer
VSVinit Shanbhag
Vinit Shanbhag
KFKevin Muñoz Forti
Kevin Muñoz Forti
LWLucas T. Woods
Lucas T. Woods
NGNikita S. Gudekar
Nikita S. Gudekar
MPMichael J. Petris
Michael J. Petris

1 January 2018 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Open access
KFKevin Muñoz Forti
Kevin Muñoz Forti
FBFaviola Bernard
Faviola Bernard
GSGustavo Santiago-Collazo
Gustavo Santiago-Collazo
WGWaldemar Garcia
Waldemar Garcia
JVJose L Vera
Jose L Vera
EMEdu Suarez Martinez
Edu Suarez Martinez
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.

Verified
Journal Article
Open access
PDF file
MFMaria Milagros Figueroa-Rosado
Maria Milagros Figueroa-Rosado
KFKevin Muñoz Forti
Kevin Muñoz Forti
PRPatricia Coral Rodriguez-Rodriguez
Patricia Coral Rodriguez-Rodriguez
GAGerardo A Arroyo-Martinez
Gerardo A Arroyo-Martinez
VIValerie Rodriguez Irizarry
Valerie Rodriguez Irizarry
EMEdu Suarez Martinez
Edu Suarez Martinez
Lung cancer remains the most common malignancy independent of sex. Here, we focused on unraveling the molecular mechanisms of CaS nanoclusters inducing cytotoxicity by investigating DNA damage, the cell cycle, oxidative stress, and cellular repair mechanisms in non-small-cell lung carcinoma (NSCLC) cells compared to healthy lung fibroblasts. Our previous studies have demonstrated the therapeutic potential of calcium sulfide (CaS) nanostructures in skin and breast cancer models, leading to a significant reduction in cancer cell proliferation. However, how CaS nanoclusters enhance their therapeutic effects on cancer cells while minimizing damage to healthy cells remains unknown. Our results show that CaS nanoclusters, once dissociated into Ca2+ and H2S in an acidic microenvironment, selectively allow extracellular calcium to enter, leading to an increase in free calcium entry, triggering oxidative stress and limiting DNA repair mechanisms in NSCLC. Furthermore, CaS nanoclusters selectively arrest NSCLC cells in the G0-G1 and S phases of the cell cycle without affecting healthy cells’ cycles. Here, we also show that the selective effects of CaS nanoclusters on lung adenocarcinoma are less likely to be regulated by intrinsic apoptotic or mitochondrial pathways. They are, rather, caused by an increase in Ca2+ and ROS, causing double-stranded DNA breakages. This selectivity for malignant cells is pH-dependent because it occurs in the acidic microenvironment characteristic of these cells. Overall, this is the first piece of evidence that CaS disrupts genomic stability, prevents the replication of damaged cells, and ultimately influences cell fate decisions such as cell cycle arrest or cell death including mitotic catastrophe and necroptotic simultaneous events.

25 March 2026 in Matrix Biology
Verified
Journal Article
Closed access
JGJulien Guillard
Julien Guillard
JSJessica Stradley
Jessica Stradley
KTKristof Turan
Kristof Turan
MSMarta R. Storl-Desmond
Marta R. Storl-Desmond
SLShan Lin
Shan Lin
SSSimon Schwӧrer
Simon Schwӧrer